|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ CompletedNot Applicable Demonstrate the Water Resistance Properties of Metal Oxide Filters
This study is designed to determine the Sun Protection Factor (SPF) of a test product following 80 Minute Water Immersion methodology defined in Final Monograph - Code of Federal Regulations Title 21 - "Labeling and Effectiveness Testing; Sunscreen Drug Products; Required Labeling Based on Effectiveness Testing", Final Rule, 21 CFR 201.327.(j)
A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of 0.1% Uracil Topical Cream (UTC) in the Prevention of Hand-Foot Syndrome (HFS) in Patients With Metastatic Breast Cancer Treated With Capecitabine
The purpose of this research study is to see if combining uracil cream (UTC) with capecitabine (Xeloda) can prevent Hand-Foot Syndrome. The study will also see what effects UTC and capecitabine may have in patients with metastatic breast cancer.
100 Clinical Results associated with Nanometics LLC
0 Patents (Medical) associated with Nanometics LLC
01 Apr 2022·Journal of the American Academy of DermatologyQ1 · MEDICINE
Frequency of procedural and medical treatments of actinic keratosis
Q1 · MEDICINE
Letter
Author: Mahon, Andrew B ; Muddasani, Suraj ; Feldman, Steven R ; Ranpariya, Varun K
100 Deals associated with Nanometics LLC
100 Translational Medicine associated with Nanometics LLC